CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 23.88% and 0.78%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Cigna (CI) Maintain Its Beat Streak in Q3 Earnings?
by Zacks Equity Research
Cigna's (CI) Q3 results are likely to reflect revenue growth owing to a strong fundamental performance. Earnings, however, might have been affected by steep medical costs from moderation in deferment of care related to the COVID-19 pandemic.
What's in the Cards for CVS Health (CVS) in Q3 Earnings?
by Zacks Equity Research
CVS Health's (CVS) Q3 earnings might have been affected by issues like lower prescription and soft front store volume due to decline in provider visits.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here Are the Factors Influencing Aaron's (AAN) Q3 Earnings
by Zacks Equity Research
Despite the continuity of the COVID-19 outbreak-related woes, strength in the Progressive segment, solid online sales and a robust lease portfolio are likely to have aided Aaron's (AAN) Q3 results.
CVS Health (CVS) Stock Moves -1.15%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $59.56 in the latest trading session, marking a -1.15% move from the prior day.
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS, Walgreens Boots, Rite Aid, Amazon and Herbalife
2 Top Retail Pharmacy and Drug Store Stocks to Beat Volatility
by Urmimala Biswas
Social-distancing measures to combat coronavirus have dented demand for Retail Pharmacy and Drug Store industry, casting a shadow on its outlook. Industry participants like CVS and HLF however seem to be in a position to tide over the situation.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $59.43 in the latest trading session, marking a +1.11% move from the prior day.
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $58.51, moving -1.03% from the previous trading session.
UnitedHealth Expands Offers to Tap Medicare Advantage Market
by Zacks Equity Research
UnitedHealth's (UNH) Medicare Advantage expansion in new counties and states with attractive price and a slew of product and service offerings to grow its market share.
Evaluating Struggling Walgreens (WBA) Stock Ahead of Q4 Earnings
by Benjamin Rains
Walgreens Boots Alliance (WBA) hasn't gained any sustained momentum during the market comeback, with the stock down 37% in 2020, against the S&P 500's 8% jump...
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - October 06, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $58.95 in the latest trading session, marking a +1.94% move from the prior day.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $57.54 in the latest trading session, marking a -0.69% move from the prior day.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - September 29, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Stock Moves -1.27%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $57.40, marking a -1.27% move from the previous day.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - September 21, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $58.41, marking a +1.62% move from the previous day.
The Zacks Analyst Blog Highlights: Walmart, Oracle, Sanofi, Amazon, GlaxoSmithKline and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, Oracle, Sanofi, Amazon, GlaxoSmithKline and CVS Health
CVS Health Retail Prescription Volume Grows Despite LTC Woes
by Zacks Equity Research
CVS Health's (CVS) consumer centric digital strategy has become even more relevant now.